Both PK and newer TSPO ligands have been key in elucidating how changes in TSPO expression, both spatially and temporally, relate to the pathogenesis of stroke and highlight a conceivable role for novel anti-inflammatory substances in the long-term management of stroke. The gene discussed is TSPO; the disease is Stroke.